DE
About us
Company
Strategy & Mission
Management
Career
Portfolio
Pipeline
Virology
Immunology
Partnering
Business Development
Solv4U
Investors & ESG
Investment Highlights
Share information
Ad-hoc News
Financial publications
Facts & Figures
Financial Calendar
Responsibility & ESG
Annual General Meeting
Capital Transactions
News
Corporate News
Scientific Publications
Events & Press
Downloads
DE
01. July 2021 | Corporate News
Marinomed Biotech AG Reports Encouraging Topline Data for Phase II Clinical Trial of Tacrosolv in Allergic Rhinoconjunctivitis
Marinomed Biotech AG
News
Press release
The full press release is available as download here:
Marinomed Biotech AG Reports Encouraging Topline Data for Phase II Clinical Trial of Tacrosolv in Allergic Rhinoconjunctivitis
(147 KB)
